AT
Andrew Tsai Jefferies Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Sarepta Therapeutics
SRPT
$1.96B
| $18.71 | $35 |
87%
upside
| Buy |
24 Jul ‘25
1 month ago |
|
2
Stoke Therapeutics
STOK
$1.13B
| $20.68 | $30 |
45%
upside
| Buy |
18 Jul ‘25
1 month ago |
|
3
BridgeBio Pharma
BBIO
$10.2B
| $53.38 | $70 |
31%
upside
| Buy |
14 Jul ‘25
1 month ago |
|
|
VRNA
4
Verona Pharma
VRNA
$9.2B
| $106.31 | $110 |
3%
upside
| Buy |
11 Jun ‘25
2 months ago |
|
5
Rocket Pharmaceuticals
RCKT
$354M
| $3.28 | $2.50 |
24%
downside
| Hold |
28 May ‘25
3 months ago |
|
6
Axsome Therapeutics
AXSM
$6.25B
| $125.17 | $200 |
60%
upside
| Buy |
7 Apr ‘25
5 months ago |
|
7
KE Holdings
BEKE
$22.4B
| $18.99 | $27 |
42%
upside
| Overweight |
19 Mar ‘25
5 months ago |
|
8
Relmada Therapeutics
RLMD
$54.8M
| $1.65 | $13 |
688%
upside
| Buy |
17 Sep ‘24
11 months ago |
|
|
RAPP
9
Rapport Therapeutics
RAPP
$524M
| $14.36 | $35 |
144%
upside
| Buy |
2 Jul ‘24
1 year ago |
|
10
Alto Neuroscience
ANRO
$99.4M
| $3.67 | $33 |
799%
upside
| Buy |
27 Feb ‘24
1 year ago |
|
11
VistaGen Therapeutics
VTGN
$109M
| $3.55 | $15 |
323%
upside
| Buy |
7 Dec ‘23
1 year ago |
|
12
Lexicon Pharmaceuticals
LXRX
$396M
| $1.09 | $3 |
175%
upside
| Hold |
7 Mar ‘23
2 years ago |
|
13
Athira Pharma
ATHA
$15.4M
| $0.3903 | $3 |
669%
upside
| Hold |
23 Jun ‘22
3 years ago |
|
14
ATAI Life Sciences
ATAI
$980M
| $4.57 | $27 |
491%
upside
| Buy |
1 Sep ‘21
4 years ago |
|
15
Xenon Pharmaceuticals
XENE
$3.02B
| $39.21 | $23 |
41%
downside
| Buy |
1 Jun ‘20
5 years ago |
|